CMT-SACS

SACS | 2018

What Is CMT-SACS?

CMT-SACS is a type of CMT caused by autosomal recessive mutations in the SACS gene. This gene provides instructions for making sacsin, a large protein that supports the maintenance of the nerve cell cytoskeleton and mitochondria. Mutations in the SACS gene disrupt this function, leading to impaired nerve signal transmission.

CMT-SACS is autosomal recessive, meaning that both copies of the gene must have a mutation to cause this subtype.

Clinical Features

The age of symptom onset in CMT-SACS is variable, ranging from childhood to adulthood. Symptoms typically begin in the lower extremities and progress over time to involve the upper limbs. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

CMT-SACS symptoms may include:

  • Weakness in the feet and lower legs
  • Muscle atrophy
  • Foot drop
  • Reduced or absent reflexes
  • Reduced sensation
  • A steppage-style walking pattern
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Progressive involvement of the hands and forearms
  • Difficulty with fine motor skills and manual dexterity
  • Additional symptoms not listed here

Disease Course

CMT-SACS shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
CMT-SACS

Classification
Unclassified Subtypes

Neuropathy Type
Axonal

Inheritance Pattern
autosomal recessive

Genetic Context

HGNC-Approved Gene Symbol
SACS

Gene Full Name
sacsin molecular chaperone

Chromosome
13q12.12

Zygosity of Responsible Variant
Homozygous

Mitochondrial Involvement
Yes

Variant Mechanism

Loss of Function (LoF)

Details

Mechanistic basis:
Complete loss

Confidence:
High

Prediction:
Published work on ARSACS supports a biallelic loss-of-function mechanism for CMT-SACS: SACS encodes sacsin, a 4,579-residue chaperone built from a ubiquitin-like domain, HSP90-like ATPase repeat regions, a DnaJ domain that recruits HSP70, and a HEPN domain. Recessive truncating variants, including the Quebec founder alleles c.6594delT and c.5254C>T, remove the protein, while destabilizing missense alleles deplete it. Cells without sacsin show bundled neurofilaments and abnormally fused, mislocalized mitochondria, the signature seen in patient fibroblasts and Sacs-null mice.

Rationale:
Sacsin behaves as a dose-dependent chaperone: obligate carriers of the founder truncations are neurologically normal, while cells with none of the protein show the full neurofilament and mitochondrial phenotype. Nonsense, frameshift, splice, and destabilizing missense alleles all converge on one clinical picture, the allelic pattern of a deficiency and not of a mutant species acting on its wild-type partner.

ClinVar Pathogenic Variants

View SACS ClinVar Variants

SACS OMIM Entry

SACS OMIM

More Info

CMT-SACS Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

Early-Onset Axonal Charcot-Marie-Tooth Disease Due to Sacs Mutation

Authors

Souza, P. V. S., Bortholin, T., Naylor, F. G. M., Pinto, W. B. V. R., & Oliveira, A. S. B.

Publication Date
February 1, 2018

Updated: August 8, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.